A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics

See also
Status	Clinical Trial	Phase
Completed	`NCT05990660` - Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery	N/A
Recruiting	`NCT04096547` - Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
Completed	`NCT04024332` - Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects	Phase 1
Completed	`NCT02849964` - Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions	N/A
Active, not recruiting	`NCT03672110` - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen	Phase 3
Completed	`NCT01462136` - PK Study of ACHN-490 Injection in Renally Impaired Subjects	Phase 1
Completed	`NCT01407874` - A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency	Phase 2
Completed	`NCT01172431` - Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency	Phase 4
Completed	`NCT01545531` - Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance	N/A
Completed	`NCT00765830` - Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)	Phase 3
Completed	`NCT00770081` - Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)	Phase 3
Terminated	`NCT00338455` - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC	Phase 2
Completed	`NCT00159614` - Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment	Phase 2
Completed	`NCT02894385` - Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)	Phase 1
Active, not recruiting	`NCT04876963` - HOLT-ED: Holter-monitoring in End-stage Renal Disease
Not yet recruiting	`NCT03899298` - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions	Phase 1
Completed	`NCT03235375` - A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects	Phase 1
Withdrawn	`NCT03329612` - Remote Ischemic Preconditioning in ACS Patients	N/A
Recruiting	`NCT02578784` - DEB-after-Cutting Balloon-PTA in Dialysis Fistula Stenosis	N/A
Active, not recruiting	`NCT02598635` - Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis	Phase 4

NCT number	NCT02894905
Study type	Interventional
Source	Janssen Research & Development, LLC
Contact
Status	Completed
Phase	Phase 1
Start date	September 13, 2016
Completion date	August 16, 2017

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms